Susquehanna International Group, LLP Apellis Pharmaceuticals, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

21 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$28.84 - $41.15 $6.96 Million - $9.93 Million	-241,300 Reduced 23.45%	787,500 $22.7 Million
Q2 2024 Aug 15, 2024	BUY	$38.07 - $59.71 $26.9 Million - $42.2 Million	707,000 Added 219.7%	1,028,800 $39.5 Million
Q1 2024 May 07, 2024	SELL	$55.39 - $72.47 $34.6 Million - $45.2 Million	-623,900 Reduced 65.97%	321,800 $18.9 Million
Q4 2023 Feb 14, 2024	SELL	$37.14 - $64.82 $2.75 Million - $4.8 Million	-74,000 Reduced 7.26%	945,700 $56.6 Million
Q3 2023 Nov 14, 2023	BUY	$23.65 - $89.22 $20.5 Million - $77.1 Million	864,700 Added 557.87%	1,019,700 $38.8 Million
Q2 2023 Aug 11, 2023	SELL	$76.68 - $93.31 $15.6 Million - $19 Million	-203,200 Reduced 56.73%	155,000 $14.1 Million
Q1 2023 May 16, 2023	BUY	$46.59 - $66.96 $7.94 Million - $11.4 Million	170,400 Added 90.73%	358,200 $23.6 Million
Q4 2022 Feb 14, 2023	BUY	$43.24 - $61.04 $1.06 Million - $1.5 Million	24,500 Added 15.0%	187,800 $9.71 Million
Q3 2022 Nov 14, 2022	BUY	$44.76 - $69.66 $5.92 Million - $9.22 Million	132,300 Added 426.77%	163,300 $11.2 Million
Q2 2022 Aug 15, 2022	SELL	$35.07 - $59.21 $5.21 Million - $8.79 Million	-148,500 Reduced 82.73%	31,000 $1.4 Million
Q1 2022 May 16, 2022	BUY	$35.46 - $54.12 $2.77 Million - $4.23 Million	78,200 Added 77.2%	179,500 $9.12 Million
Q4 2021 Feb 14, 2022	SELL	$30.74 - $49.16 $13.1 Million - $20.9 Million	-425,500 Reduced 80.77%	101,300 $4.79 Million
Q3 2021 Nov 15, 2021	BUY	$31.4 - $69.84 $2.17 Million - $4.83 Million	69,100 Added 15.1%	526,800 $17.4 Million
Q2 2021 Aug 11, 2021	BUY	$40.9 - $64.9 $13.6 Million - $21.6 Million	333,200 Added 267.63%	457,700 $28.9 Million
Q1 2021 May 17, 2021	BUY	$40.8 - $57.39 $1.01 Million - $1.42 Million	24,700 Added 24.75%	124,500 $5.34 Million
Q4 2020 Feb 16, 2021	BUY	$30.79 - $57.2 $735,881 - $1.37 Million	23,900 Added 31.49%	99,800 $5.71 Million
Q3 2020 Nov 16, 2020	BUY	$25.89 - $33.65 $1.44 Million - $1.87 Million	55,600 Added 273.89%	75,900 $2.29 Million
Q2 2020 Aug 14, 2020	SELL	$24.8 - $38.49 $553,040 - $858,327	-22,300 Reduced 52.35%	20,300 $663,000
Q1 2020 May 15, 2020	SELL	$17.91 - $44.33 $2.03 Million - $5.02 Million	-113,200 Reduced 72.66%	42,600 $1.14 Million
Q4 2019 Feb 14, 2020	BUY	$22.1 - $30.8 $1.81 Million - $2.53 Million	82,100 Added 111.4%	155,800 $4.77 Million
Q3 2019 Nov 14, 2019	BUY	$24.09 - $32.18 $1.78 Million - $2.37 Million	73,700 New	73,700 $1.78 Million

Others Institutions Holding APLS

# of Institutions

308

Shares Held

115M

Call Options Held

3.85M

Put Options Held

1.09M

Wellington Management Group LLP Boston, MA

15.6M
Shares

$516 Million
0.08% of portfolio
Eco R1 Capital, LLC San Francisco, CA

11.9M
Shares

$394 Million
14.88% of portfolio
Avoro Capital Advisors LLC New York, NY

11.1M
Shares

$368 Million
4.82% of portfolio
Vanguard Group Inc Valley Forge, PA

9.82M
Shares

$325 Million
0.01% of portfolio
Black Rock Inc. New York, NY

5.8M
Shares

$192 Million
0.01% of portfolio

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.64B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account